Search

everythinglearnresearchcommunity

for

Search:↓

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Bimatoprost may help treat hair loss from alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The combination therapy was effective and well-tolerated, especially in young patients.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Turpentine ointment is effective and safe for treating folliculitis.

Turpentine ointment is an effective and safe treatment for folliculitis.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

PRP is an effective and safe treatment for alopecia areata.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Latisse is safe and effective for long-term eyelash growth in people with thin eyelashes from chemotherapy or unknown causes.